New Chronic Fatigue Clinical Trial at Stanford University

K-PAX is an integrative pharmaceutical company currently developing a new treatment for Chronic Fatigue Syndrome (CFS) that combines a currently available medication with a CFS Nutrient Formula designed to enhance mitochondrial energy production.

This treatment has already been taken by over two dozen patients with CFS and the results have been extremely positive. Based on the very positive results seen in this preliminary investigation, we are now recruiting 120 patients for a Phase II double-blind, placebo-controlled clinical trial that is being conducted at the following four research sites:

· Palo Alto (Stanford University)
· Fort Lauderdale, FL
· Manhattan, NY
· Salt Lake City, UT

Eligibility information can be found at www.thesynergytrial.org

Thank you for sharing this information with those who are suffering from chronic fatigue.

No one over 59 need apply. Sorry fellow old timers.